Infection risk and cost-effectiveness of commercial bags or glass bottles for total parenteral nutrition

Infection Control and Hospital Epidemiology

Volumn 18, Issue 3, 1997, Pages 183-188

  Durand Zaleski, Isabelle ^a   Delaunay, Laurent ^a   Langeron, Olivier ^a   Belda, Eric ^a   Astier, Alain ^a   Brun Buisson, Christian ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLASS;

ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; CROSS INFECTION; DRUG PACKAGING; ECONOMICS; FRANCE; HOSPITAL COST; HOSPITAL EQUIPMENT; HUMAN; INSTRUMENTATION; LENGTH OF STAY; RISK FACTOR; SOCIOECONOMICS; STANDARD; TOTAL PARENTERAL NUTRITION;

COST-BENEFIT ANALYSIS; CROSS INFECTION; DRUG PACKAGING; EQUIPMENT AND SUPPLIES, HOSPITAL; FRANCE; GLASS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; PARENTERAL NUTRITION, TOTAL; RISK FACTORS; VALUE OF LIFE;

EID: 0031087693     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141979     Document Type: Article

References (28)

1. Armstrong CW, Mayhall CG, Miller KB. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis 1986;154:808-816.
2. Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA. Total parenteral nutrition-related infection. Prospective epidemiological study using semi-quantitative methods. Am J Med 1982;73:695-699.
3. Raad II, Bodey G. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197-210.
4. Drummond M, Stoddart G, Torrance G. Methods for Economic Evaluation of Health Care Programmes. Oxford, England: Oxford University Press; 1989:18-34, 74-83.
5. Office Canadien de Coordination de l'Evaluation des Technologies de la Santé, Ottawa, Ontario, Canada. Lignes directrices pour l'évaluation économique des produits pharmaceutiques; 1994.
6. Robinson R. Economic evaluation and health care: what does it mean? BMJ 1993;307:670-673.
7. Robinson R. Costs and cost-minimization analysis. BMJ 1993; 307:726-728.
8. Robinson R. Cost-effectiveness analysis. BMJ 1993;307:793-795.
9. Howard L, Claunch C, MC Dowell R, Timchalk M. Five years of experience in patients receiving home nutritional support with the implanted reservoir: a comparison with the external catheter. JPEN J Parenter Enterai Nutr 1989;13:478-483.
10. Hulliger S, Pittet D. Incidence, morbidité et mortalité des infections dues aux cathéters veineux centraux en réanimation. Réan Urg 1994;3:365-369.
11. Pittet D, Tatara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs and attributable mortality. JAMA 1994;217:1598-1601.
12. Daschner F. Nosocomial infections in intensive care units. Intensive Care Med 1985;11:284-287.
13. Daschner F. The cost of hospital-acquired infection. J Hosp Infect 1984;5S:27-33.
14. Arnow P, Quimosing E, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993;16:778-784.
15. Martone WJ, Jarvis WR Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infection. Hospital Infections. 3rd ed. Boston, MA: Little, Brown & Co; 1992.
16. Gaynes R, Culver D, Emori G, et al. The nosocomial infections surveillance system and beyond: plans for the 1990s and beyond. Am J Med 1991;91(suppl 3B):116S-120S.
17. Wakefield DS, Hems CM, Massanari RM, Mon M, Pfaller M. The cost of nosocomial infection: relative contribution of laboratory, antibiotic and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185-192.
18. Garo B, Boles JM, Renault A. Evaluation médico-économique du coût de l'infection nosocomiale. Actualités en Réanimation et Urgences. Paris, France: Arnette-Blackwell; 1995.
19. Société de Réanimation de langue française. Utilisation de l'indice de gravité simplifié et du système oméga. Réan Soins Intens Urg 1986;2:219-221.
20. Haley RW, Schaberg DR Crossley KB, Von Allmen SD, McGowan JE Jr. Extra charges and prolongation of stay attributable to nosocomial infections; a prospective interhospital comparison. Am J Med 1981;70:51-58.
21. Weinstein M. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assessment Health Care 1990;6:93-106.
22. Veluchamy S, Saver C. Clinical technology assessment, cost-effective adoption and quality management by hospitals in the 1990s. Qual Rev Bull 1990;16:223-228.
23. Drummond M. Cost-effectiveness guidelines for the reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status? Health Econ 1992;1:85-92.
24. Torrance G, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-575.
25. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.
26. Dixon R. Effect of infections on hospital care. Ann Intern Med 1978;89:749-753.
27. Steinberg E, Graziano S. Integrating technology assessment and medical practice evaluation into hospital operation. Qual Rev Bull 1990;16:218-222.
28. Steiner D, Norman G. Health Measurement Scales. Oxford, England: Oxford University Press; 1993.